C. Edan

1.9k total citations
29 papers, 1.1k citations indexed

About

C. Edan is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, C. Edan has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Genetics and 8 papers in Pathology and Forensic Medicine. Recurrent topics in C. Edan's work include Glioma Diagnosis and Treatment (7 papers), Neuroblastoma Research and Treatments (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). C. Edan is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Neuroblastoma Research and Treatments (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). C. Edan collaborates with scholars based in France, Belgium and United Kingdom. C. Edan's co-authors include C Kalifa, Didier Frappaz, François Doz, Éric Bouffet, Catherine Patte, M.C. Baranzelli, Pascal Chastagner, Jacques Grill, Marie‐Cécile Le Deley and Jean‐Claude Gentet and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

C. Edan

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Edan France 15 580 324 314 234 218 29 1.1k
Odile Lejars France 16 416 0.7× 343 1.1× 328 1.0× 298 1.3× 141 0.6× 28 980
L. Kun United States 12 613 1.1× 420 1.3× 203 0.6× 450 1.9× 427 2.0× 21 1.5k
Carolyn Russo United States 16 414 0.7× 292 0.9× 260 0.8× 209 0.9× 133 0.6× 31 1.1k
Jean Claude Gentet France 24 569 1.0× 522 1.6× 418 1.3× 474 2.0× 79 0.4× 46 1.4k
Clifford C. Bailey United Kingdom 13 439 0.8× 187 0.6× 270 0.9× 169 0.7× 178 0.8× 17 758
Blanca Diez Argentina 19 1.1k 1.8× 497 1.5× 290 0.9× 387 1.7× 165 0.8× 40 1.5k
Diane Puccetti United States 11 482 0.8× 272 0.8× 310 1.0× 159 0.7× 107 0.5× 24 953
H. Rao Gattamaneni United Kingdom 23 444 0.8× 451 1.4× 371 1.2× 292 1.2× 443 2.0× 40 1.9k
Karin Dieckmann Austria 21 375 0.6× 233 0.7× 85 0.3× 373 1.6× 98 0.4× 51 1.0k
Alfred Grovas United States 11 225 0.4× 253 0.8× 206 0.7× 334 1.4× 69 0.3× 17 737

Countries citing papers authored by C. Edan

Since Specialization
Citations

This map shows the geographic impact of C. Edan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Edan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Edan more than expected).

Fields of papers citing papers by C. Edan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Edan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Edan. The network helps show where C. Edan may publish in the future.

Co-authorship network of co-authors of C. Edan

This figure shows the co-authorship network connecting the top 25 collaborators of C. Edan. A scholar is included among the top collaborators of C. Edan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Edan. C. Edan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fiévet, Alice, Marc‐Antoine Belaud‐Rotureau, Frédéric Dugay, et al.. (2013). Involvement of germline DDX1–MYCN duplication in inherited nephroblastoma. European Journal of Medical Genetics. 56(12). 643–647. 14 indexed citations
3.
Chappé, Céline, Laurent Riffaud, Catherine Tréguier, et al.. (2013). Primary gliomatosis cerebri involving gray matter in pediatrics: a distinct entity? A multicenter study of 14 cases. Child s Nervous System. 29(4). 565–571. 11 indexed citations
4.
Oberlin, Odile, Thierry Leblanc, Hélène Pacquement, et al.. (2012). Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE). British Journal of Haematology. 158(5). 649–656. 24 indexed citations
5.
Rizzo, Daniela, Paul Fréneaux, Hervé J. Brisse, et al.. (2012). SMARCB1 Deficiency in Tumors From the Peripheral Nervous System. The American Journal of Surgical Pathology. 36(7). 964–972. 26 indexed citations
6.
Dufour, Christelle, Marie‐Cécile Le Deley, Franck Bourdeaut, et al.. (2011). Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system. Cancer. 118(15). 3812–3821. 76 indexed citations
7.
Pagnier, Anne, C. Edan, Judith Landman‐Parker, et al.. (2011). Maladie de Hodgkin et auto-immunité chez l’enfant : à propos de 11 observations. Archives de Pédiatrie. 18(4). 376–382. 5 indexed citations
8.
Taque, Sophie, et al.. (2010). School Performance of Childhood Cancer Survivors: Mind the Teenagers!. The Journal of Pediatrics. 158(1). 135–141. 47 indexed citations
9.
Leblanc, Thierry, Anne Lambilliotte, Hélène Pacquement, et al.. (2010). CL099 - Évaluation des recommandations MDH03 pour le traitement des lymphomes de Hodgkin de l’enfant. Archives de Pédiatrie. 17(6). 29–30. 1 indexed citations
10.
Battistella, Maxime, Martina Prochazkova‐Carlotti, D. Berrebi, et al.. (2010). Two Congenital Cases of Pigmented Epithelioid Melanocytoma Studied by Fluorescent in situ Hybridization for Melanocytic Tumors: Case Reports and Review of These Recent Topics. Dermatology. 221(2). 97–106. 16 indexed citations
12.
Verlooy, Joris, Véronique Mosseri, Serge Bracard, et al.. (2006). Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study. European Journal of Cancer. 42(17). 3004–3014. 56 indexed citations
13.
Henry, Cathérine, Virginie Gandemer, Florence Burtin, et al.. (2005). Late ovarian relapse of TEL/AML1 positive ALL confirming that TEL deletion is a secondary event in leukemogenesis. Leukemia Research. 29(9). 1089–1094. 13 indexed citations
14.
Kalifa, C, Jean Claude Gentet, Didier Frappaz, et al.. (2005). Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology Study. Journal of Clinical Oncology. 23(21). 4726–4734. 99 indexed citations
15.
Gandemer, Virginie, et al.. (2003). Impact of Topoisomerase II alpha and Spermine on the clinical outcome of children with acute lymphoblastic leukemia. Leukemia Research. 28(5). 479–486. 13 indexed citations
16.
Godey, Benoît, et al.. (2000). Primary Retropharyngeal Neuroblastoma. Archives of Otolaryngology - Head and Neck Surgery. 126(9). 1150–1150. 4 indexed citations
17.
Bouffet, Éric, M.C. Baranzelli, Catherine Patte, et al.. (1999). Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. British Journal of Cancer. 79(7-8). 1199–1204. 115 indexed citations
18.
Costet, Nathalie, Jean‐Claude Gentet, C Kalifa, et al.. (1999). Cross-cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3. International Journal of Cancer. 83(S12). 112–118. 38 indexed citations
19.
Edan, C., et al.. (1994). [Orbital rhabdomyosarcoma in children. Apropos of 2 cases].. PubMed. 17(1). 67–73. 4 indexed citations
20.
Bergeron, Christophe, Philippe Le Moine, H Jouan, et al.. (1993). Cerebral non‐Hodgkin's lymphoma discovered when treating Hodgkin's disease. Medical and Pediatric Oncology. 21(4). 307–310.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026